{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:08:39Z","timestamp":1784740119402,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The expression of chemokine receptors CCR7 has been studied in relation to tumor dissemination and poor prognosis in a limited number of cancers. No such studies have been done on CCR7 expression in non-Hodgkin's lymphoma (T-NHL). Our aim in this paper is to investigate the association between CCR7 expression and progression and prognosis of T-NHL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>1) Analysis of clinical data: The specimens were obtained from 41 patients with T-NHL and 19 patients with lymphoid hyperplasia. Their corresponding clinicopathologic data were also collected. The expression levels of CCR7, MMP-2, and MMP-9 were examined by immunohistochemical staining. 2) Human T-NHL cell lines Hut 78 (cutaneous T-cell lymphoma) and Jurkat (adult T-cell leukemia\/lymphoma) were cultured. The invasiveness of the two cell lines were measured with a Transwell invasion assay, and then used to study the effects of chemokine receptors on T-NHL invasion and the underlying molecular mechanism. The transcript and expression of CCR7 were evaluated using RT-PCR and western blotting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1) The higher CCR7 and MMP-9 expression ratios were significantly associated with multiple lesions and higher stage III\/IV. Moreover, a positive correlation was observed between CCR7 and MMP-9 expression. 2) The Hut 78 cell line was more invasive than the Jurkat cells in the Transwell invasion assay. The transcript and expression levels of CCR7 were significantly higher in Hut78 than that of Jurkat cell line. The T-NHL cell lines were co-cultured with chemokine CCL21 which increased the invasiveness of T-NHL cell. The positive association between CCL21 concentration and invasiveness was found. 3) The stronger transcript and expression of PI<jats:sub>3<\/jats:sub>K, Akt and p- Akt were also observed in Hut78 than in Jurkat cell line.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High CCR7 expression in T-NHL cells is significantly associated with lymphatic and distant dissemination as well as with tumor cell migration and invasion<jats:italic>in vitro<\/jats:italic>. Its underlying mechanism probably involves the PI<jats:sub>3<\/jats:sub>K\/Akt signal pathway.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1756-9966-30-51","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T18:14:20Z","timestamp":1304792060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Effect of Chemokine Receptors CCR7 on Disseminated Behavior of Human T cell Lymphoma: clinical and experimental study"],"prefix":"10.1186","volume":"30","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baocun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,7]]},"reference":[{"key":"473_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1185\/030079903125002216","volume":"19","author":"M Arya","year":"2003","unstructured":"Arya M, Patel HR, Williamson M: Chemokines: key players in cancer. Curr Med Res Opin. 2003, 19: 557-64.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"473_CR2","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1074\/jbc.273.12.7118","volume":"273","author":"R Yoshida","year":"1998","unstructured":"Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O: Secondary lymphoid tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. Biol Chem. 1998, 273 (12): 7118-7122. 10.1074\/jbc.273.12.7118.","journal-title":"Biol Chem"},{"key":"473_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1084\/jem.188.2.373","volume":"188","author":"MC Dieu","year":"1998","unstructured":"Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, A\u00eft-Yahia S, Bri\u00e8re F, Zlotnik A, Lebecque S, Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. Exp Med. 1998, 188: 373-86. 10.1084\/jem.188.2.373.","journal-title":"Exp Med"},{"key":"473_CR4","first-page":"2209","volume":"60","author":"M Hirao","year":"2000","unstructured":"Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, Robbins PD, Lotze MT, Tahara H: CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells:critical role in migration from the tumor site to draining lymph nodes. Cancer Res. 2000, 60: 2209-17.","journal-title":"Cancer Res"},{"key":"473_CR5","first-page":"3406","volume":"9","author":"Y Ding","year":"2003","unstructured":"Ding Y, Shimada Y, Maeda M, Kawabe A, Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H, Imamura M: Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003, 9: 3406-12.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"473_CR6","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-03-0195","volume":"10","author":"H Takeuchi","year":"2004","unstructured":"Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS: CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res. 2004, 10 (7): 2351-2358.","journal-title":"Clin Cancer Res"},{"key":"473_CR7","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.4049\/jimmunol.162.5.2472","volume":"162","author":"H Saeki","year":"1999","unstructured":"Saeki H, Moore AM, Brown MJ, Hwang ST: Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol. 1999, 162: 2472-75.","journal-title":"J Immunol"},{"key":"473_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4161\/cbt.3.1.547","volume":"3","author":"T Mori","year":"2004","unstructured":"Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K, Masui T, Fujimoto K, Tamamura H, Hiramatsu K, Fujii N, Imamura M: CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther. 2004, 3: 29-37.","journal-title":"Mol Cancer Ther"},{"key":"473_CR9","first-page":"abstract 51","volume":"45","author":"DD Twitchell","year":"2004","unstructured":"Twitchell DD, London NR, Tomer DP, Tomer S, Murray BK, O'Neill KL: Tannic acid prevents angiogenesis in vivo by inhibiting CXCR4\/SDF-1 a binding in breast cancer cells. Proc AACR. 2004, 45: abstract 51-","journal-title":"Proc AACR"},{"key":"473_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Ver\u00e1stegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410: 50-6.","journal-title":"Nature"},{"issue":"2","key":"473_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ijc.11063","volume":"105","author":"I Takanami","year":"2003","unstructured":"Takanami I: Over expression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer. 2003, 105 (2): 186-189.","journal-title":"Int J Cancer"},{"key":"473_CR12","first-page":"2937","volume":"62","author":"K Mashino","year":"2002","unstructured":"Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, Inoue H, Mori M: Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 2002, 62: 2937-41.","journal-title":"Cancer Res"},{"key":"473_CR13","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/jnci\/93.21.1638","volume":"93","author":"HE Wiley","year":"2001","unstructured":"Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST: Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst. 2001, 93: 1638-43.","journal-title":"J Natl Cancer Inst"},{"key":"473_CR14","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.194.12.1875","volume":"194","author":"G Henning","year":"2001","unstructured":"Henning G, Ohl L, Junt T, Reiterer P, Brinkmann V, Nakano H, Hohenberger W, Lipp M, F\u00f6rster R: CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med. 2001, 194: 1875-81.","journal-title":"J Exp Med"},{"key":"473_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1084\/jem.20020201","volume":"196","author":"T Okada","year":"2002","unstructured":"Okada T, Ngo VN, Ekland EH, F\u00f6rster R, Lipp M, Littman DR, Cyster JG: Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med. 2002, 196: 65-75.","journal-title":"J Exp Med"},{"key":"473_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/blood-2002-03-0841","volume":"101","author":"JV Stein","year":"2003","unstructured":"Stein JV, Soriano SF, M'rini C, Nombela-Arrieta C, de Buitrago GG, Rodr\u00edguez-Frade JM, Mellado M, Girard JP, Mart\u00ednez-AC C: CR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood. 2003, 101: 38-44.","journal-title":"Blood"},{"issue":"6","key":"473_CR17","first-page":"528","volume":"19","author":"F Ma","year":"2003","unstructured":"Ma F, Zhang SR, Ning L, Sun WX, Liang X, Zhang XY, Fu M, Lin C: Construction of eukaryotic expression vector of murine SLC gene and characterization of its chemotactic function. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003, 19 (6): 528-30.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"7249","key":"473_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/nature08020","volume":"459","author":"S Buonamici","year":"2009","unstructured":"Buonamici S, Trimarchi T, Ruocco MG, Reavie L, Cathelin S, Mar BG, Klinakis A, Lukyanov Y, Tseng JC, Sen F, Gehrie E, Li M, Newcomb E, Zavadil J, Meruelo D, Lipp M, Ibrahim S, Efstratiadis A, Zagzag D, Bromberg JS, Dustin ML, Aifantis I: CCR7 signaling as an essential regulator of CNS infiltration in T-cell leukemia. Nature. 2009, 459 (7249): 1000-4.","journal-title":"Nature"},{"key":"473_CR19","first-page":"123","volume-title":"Molecular biology of cancer: invasion and metastases","author":"WG Stetler-Stevenson","year":"2001","unstructured":"Stetler-Stevenson WG, Kleiner DE: Molecular biology of cancer: invasion and metastases. Philadelphia: Lippincott & Wilkins, 2001, 123-36."},{"issue":"6A","key":"473_CR20","first-page":"4073","volume":"20","author":"T Nomura","year":"2000","unstructured":"Nomura T, Hasegawa H: Chemokines and anti-cancer immunotherapy: Anti-tumor effect of EBL1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC). Anticancer Res. 2000, 20 (6A): 4073-4080.","journal-title":"Anticancer Res"},{"key":"473_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.cellbio.17.1.615","volume":"17","author":"R Katso","year":"2001","unstructured":"Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD: Cellular function of phosphoinositide-3-kinases: imp lications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2001, 17: 615-675.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"473_CR22","first-page":"25","volume":"11","author":"X Xu","year":"2005","unstructured":"Xu X, Sakon M, Nagano H, Hiraoka N, Yamamoto H, Hayashi N, Dono K, Nakamori S, Umeshita K, Ito Y, Matsuura N, Monden M: Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol Rep. 2005, 11: 25-32.","journal-title":"Oncol Rep"},{"key":"473_CR23","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-02-1441","volume":"10","author":"S Yamamoto","year":"2004","unstructured":"Yamamoto S, Tomita Y, Hoshida Y, Morooka T, Nagano H, Dono K, Umeshita K, Sakon M, Ishikawa O, Ohigashi H, Nakamori S, Monden M, Aozasa K: Prognostic significance of activated akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2004, 10: 2846-2850.","journal-title":"Clin Cancer Res"},{"key":"473_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0065-230X(05)94002-5","volume":"94","author":"A Bellacosa","year":"2005","unstructured":"Bellacosa A, Kumar CC, Di Cristofano A, Testa JR: Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005, 94: 29-86.","journal-title":"Adv Cancer Res"},{"key":"473_CR25","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","volume":"24","author":"DA Altomare","year":"2005","unstructured":"Altomare DA, Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005, 24: 7455-7464.","journal-title":"Oncogene"},{"key":"473_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","volume":"14","author":"KM Nicholson","year":"2002","unstructured":"Nicholson KM, Anderson NG: The protein kinase B\/Akt signaling pathway in human malignancy. Cell Signal. 2002, 14: 381-395.","journal-title":"Cell Signal"},{"issue":"3","key":"473_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/blood-2003-11-3943","volume":"104","author":"N S\u00e1nchez-S\u00e1nchez","year":"2004","unstructured":"S\u00e1nchez-S\u00e1nchez N, Riol-Blanco L, de la Rosa G, Puig-Kr\u00f6ger A, Garc\u00eda-Bordas J, Mart\u00edn D, Longo N, Cuadrado A, Caba\u00f1as C, Corb\u00ed AL, S\u00e1nchez-Mateos P, Rodr\u00edguez-Fern\u00e1ndez JL: Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood. 2004, 104 (3): 619-","journal-title":"Blood"},{"issue":"4","key":"473_CR28","first-page":"255","volume":"52","author":"K Nabeshima","year":"2002","unstructured":"Nabeshima K, Inoue T, Shimao Y, Sameshima T: Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Annual. 2002, 52 (4): 255-264.","journal-title":"Pathol Annual"},{"key":"473_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/cncr.11905","volume":"100","author":"K Sakata","year":"2004","unstructured":"Sakata K, Satoh M, Someya M, Asanuma H, Nagakura H, Oouchi A, Nakata K, Kogawa K, Koito K, Hareyama M, Himi T: Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgekin's lymphoma. Cancer. 2004, 100: 356-365.","journal-title":"Cancer"},{"issue":"19","key":"473_CR30","first-page":"5543","volume":"62","author":"M Arlt","year":"2002","unstructured":"Arlt M, Kopitz C, Pennington C, Watson KL, Krell HW, Bode W, Gansbacher B, Khokha R, Edwards DR, Kr\u00fcger A: Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res. 2002, 62 (19): 5543-5550.","journal-title":"Cancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-30-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T17:12:05Z","timestamp":1686071525000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-30-51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-30-51","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,7]]},"assertion":[{"value":"9 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"51"}}